| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/31/2011 | WO2011038157A2 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins |
| 03/31/2011 | WO2011038152A2 Toll-like receptor modulators and uses thereof |
| 03/31/2011 | WO2011038097A2 Indolizine inhibitors of 5-lipoxygenase |
| 03/31/2011 | WO2011038086A2 Indolizine inhibitors of 5-lipoxygenase |
| 03/31/2011 | WO2011037913A2 Methods for preventing oxidative stress injury of a tissue by a folate-tempol conjugate |
| 03/31/2011 | WO2011037613A1 Crystalline forms and processes for the preparation of pgi2 receptor agonists |
| 03/31/2011 | WO2011037467A1 Atazanavir for treating inflammatory diseases |
| 03/31/2011 | WO2011037301A1 Method for derivation of pluripotent stem cells from adult cells and pluripotent stem cells produced by method |
| 03/31/2011 | WO2011037281A1 Slow-release cilostazol tablet having an improved elution rate and minimal side effects |
| 03/31/2011 | WO2011037227A1 Agent for prevention of atherosclerosis |
| 03/31/2011 | WO2011037223A1 Agent for reducing visceral fat weight |
| 03/31/2011 | WO2011037192A1 Substituted amide compound |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011036651A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 03/31/2011 | WO2011036533A1 Pharmaceutical composition comprising prasugrel and triflusal |
| 03/31/2011 | WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors |
| 03/31/2011 | WO2011036204A1 [1,4]-benzodiazepines as vasopressin v2 receptor antagonists |
| 03/31/2011 | WO2011035500A1 Use of piperphentonamine or salts thereof in manufacture of medicaments for preventing / treating brain diseases |
| 03/31/2011 | WO2010149658A3 Pharmaceutical composition comprising gamma - butyrobetaine and meldonium |
| 03/31/2011 | WO2010138610A3 Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease |
| 03/31/2011 | WO2010131910A3 Composition for improving blood circulation containing fermented tea, and pharmaceutical and health-food compositions comprising the same |
| 03/31/2011 | WO2010120905A3 Novel nano-probes for molecular imaging and targeted therapy of diseases |
| 03/31/2011 | WO2010118330A3 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease |
| 03/31/2011 | WO2010104998A3 Methods for treating heart failure by inhibiting the mitochondrial sodium-calcium exchanger (mnce) |
| 03/31/2011 | US20110077288 Pharmaceutical Compositions for Treatment of MicroRNA Related Diseases |
| 03/31/2011 | US20110077279 Angiotensin ii receptor antagonists |
| 03/31/2011 | US20110077277 Organic compounds |
| 03/31/2011 | US20110077268 Kinase inhibitors and methods of use |
| 03/31/2011 | US20110077266 Diamine Derivatives |
| 03/31/2011 | US20110077264 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 03/31/2011 | US20110077249 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
| 03/31/2011 | US20110077243 Triazolopyridine Compounds Useful As Kinase Inhibitors |
| 03/31/2011 | US20110077242 Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| 03/31/2011 | US20110077236 New carboxylic acid amides, the preparation thereof and their use as medicaments |
| 03/31/2011 | US20110077235 Apoptosis signal-regulating kinase 1 inhibitors |
| 03/31/2011 | US20110077233 C-Met Modulators and Method of Use |
| 03/31/2011 | US20110077221 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 03/31/2011 | US20110077216 Compositions and methods for the treatment of atherosclerosis and other related diseases |
| 03/31/2011 | US20110077211 Methods and compositions for treating luminal inflammatory disease |
| 03/31/2011 | US20110077198 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110077190 Selective Caspase Inhibitors and Uses Thereof |
| 03/31/2011 | US20110076334 Methods and compositions for treatment of raynaud's phenomenon |
| 03/31/2011 | US20110076331 Use of Deuterium Oxide as an Elastase Inhibitor |
| 03/31/2011 | US20110076326 Modified protein excipient for delayed-release tablet |
| 03/31/2011 | US20110076319 Bioresorbable metal stent with controlled resorption |
| 03/31/2011 | US20110076314 Hydrophobic polysaccharides with silyl ether linkages having enhanced degradation and medical articles made therefrom |
| 03/31/2011 | US20110076295 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 03/31/2011 | US20110076294 Mixed Cell Populations For Tissue Repair And Separation Technique For Cell Processing |
| 03/31/2011 | US20110076293 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 03/31/2011 | US20110076292 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076291 Benzoxepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076264 Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| 03/31/2011 | US20110076259 Detection of risk of pre-eclampsia |
| 03/31/2011 | US20110076255 Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency |
| 03/31/2011 | US20110076254 Porous scaffolds for stem cell renewal |
| 03/31/2011 | DE102009043183A1 Antihypertensive chocolate comprises high percentage of cocoa components of cocoa varieties exhibiting a high content of polyphenol and optionally an additional antihypertensive, natural food additive |
| 03/31/2011 | CA2775339A1 Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| 03/31/2011 | CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors |
| 03/31/2011 | CA2775027A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | CA2774647A1 Substituted amide compound |
| 03/31/2011 | CA2774008A1 Toll-like receptor modulators and uses thereof |
| 03/31/2011 | CA2772284A1 [1,4]-benzodiazepines as vasopressin v2 receptor antagonists |
| 03/31/2011 | CA2770278A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301931A1 Imidazoles as aldosterone synthase inhibitors |
| 03/30/2011 | EP2301930A1 Thrombin receptor antagonists |
| 03/30/2011 | EP2301922A1 Pyridone compound |
| 03/30/2011 | EP2301915A1 7-(diethylamino)methyl substituted tetracycline having target therapeutic activities |
| 03/30/2011 | EP2301563A2 HSP20 peptides |
| 03/30/2011 | EP2301550A1 Tetracycline compounds having target therapeutic activities |
| 03/30/2011 | EP2301537A1 Zonisamide for the treatment of obesity |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2301528A1 Use of FTS for treating malignant disorders |
| 03/30/2011 | EP2301343A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/30/2011 | EP2300496A1 Methods of treating atherosclerosis |
| 03/30/2011 | EP2300468A1 Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido ý 3, 2, 1-i j¨quinoline compounds |
| 03/30/2011 | EP2300425A2 Cycloalkaneýb¨indole angtagonists of prostaglandin d2 receptors |
| 03/30/2011 | EP2300423A1 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof |
| 03/30/2011 | EP2300422A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 03/30/2011 | EP2300048A1 Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks |
| 03/30/2011 | EP2300028A1 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels |
| 03/30/2011 | EP2300001A1 Dronedarone for the prevention of permanent atrial fibrillation |
| 03/30/2011 | EP2222376B1 3-(2,2,2-trimethylhydrazinium) propionate salts for treating myocardial infarction |
| 03/30/2011 | EP1838392B1 Selenium-containing medicaments for the prevention or treatment of endothelial vascular diseases |
| 03/30/2011 | EP1833821B1 Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases |
| 03/30/2011 | EP1500698B1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 03/30/2011 | EP1409006B1 Monodispersed mixtures and methods of treating diabetes |
| 03/30/2011 | EP1337242B1 Gene delivery formulations for treatment of ischemic conditions |
| 03/30/2011 | EP1305007B1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/30/2011 | CN1956995B Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 03/30/2011 | CN101998989A Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone and/or vasopressin production or release |
| 03/30/2011 | CN101998961A Substituted 2-phenyl-pyridine derivatives |
| 03/30/2011 | CN101998863A Use of anti-amyloid beta antibody in ocular diseases |
| 03/30/2011 | CN101998853A Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators |
| 03/30/2011 | CN101993475A Synthesis method of full liquid-phase Eptifibatide |
| 03/30/2011 | CN101993462A Scutellarin crystal I and preparation method thereof |
| 03/30/2011 | CN101993433A Olmesartan organic amine salt, preparation method and application thereof |
| 03/30/2011 | CN101993403A Azetidinone compound and medical applications thereof |